Is Immunome, Inc. (IMNM) a Buy, Sell, or Hold?
Immunome, Inc.
NASDAQ:IMNM
$22.92 USD
$0.33 (1.46%)
- Volume
- 1.9M
- Average Volume
- 1.35M
- Market Capitalization
- $2.19B
- P/E Ratio
- -9.59
- Dividend Yield
- 0.00%
- Price Target
- $36.50
- Year High
- $27.65
- Year Low
- $8.48
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.68
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-37.2% DOWNSIDE
$36.50 Price Target
UPSIDE/DOWNSIDE HIGH
-42.7% DOWNSIDE
$40.00 Price Target High
UPSIDE/DOWNSIDE LOW
-30.5% DOWNSIDE
$33.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Supawat Thongthip | $37 | $22.11 | 2026-05-28 06:07 AM | 67.3% |
| Barclays | Lukas Shumway | $36 | $22.11 | 2026-05-28 03:36 AM | 62.8% |
| Leerink Partners | Andrew Berens | $33 | $22.02 | 2026-05-15 06:25 AM | 49.9% |
| Truist Financial | Karina Rabayeva | $36 | $18.42 | 2025-12-01 07:08 AM | 95.4% |